1. HOME
  2. News & Presentation
  3. Tokiwa-Bio Inc. was adopted by Japan Agency for Medical Research and Development (AMED) Project for “Genetic and Cellular Therapeutic Research and Development”.

NEWS & PRESENTATION

お知らせ & 発表

NEWS

Tokiwa-Bio Inc. was adopted by Japan Agency for Medical Research and Development (AMED) Project for “Genetic and Cellular Therapeutic Research and Development”.

This project, based on the invention by Mahito Nakanishi et al, aims practical application of domestic gene therapy technology and development to the world with high track record researchers in the clinical field.
The stealth RNA vector developed by AIST overcomes the shortcomings of existing RNA virus vectors and is the world’s only universal gene that enables persistent expression by fusing a high gene transfer efficiency of a viral vector and a safe gene expression ability of a non-viral vector that developed by AIST.
Subject name “Establishment of stealth-type RNA vector technology realizing highly safe gene / cell therapy”

LATEST INFO